Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × palbociclib × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Hematologic Neoplasms 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Thrombocytosis 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Standard of Care 2 COH04S1 COVID-19 vaccine 2 remdesivir 1 palbociclib 1 ogalvibart 1 crexavibart 1 cilgavimab and tixagevimab drug combination 1 acalabrutinib 1 XAV-19 1 Therapeutics 1 Specimen Handling 1 Rabeprazole 1 Prednisone 1 Methylprednisolone 1 IBIO123 1 Glucocorticoids 1 Gelsolin 1 Dexamethasone 1 CVnCoV COVID-19 vaccine 1 COVID-19 Vaccines 1 COVID-19 Serotherapy 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1 1-palmityl-2-(4-carboxybutyl)-sn-glycero-3-phosphocholine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05371275 2022-11-07

CDK6COV

biotx.ai GmbH

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡